Author: Healio ophthalmology

Ocular Therapeutix submits premarket approval application for hydrogel sealant

Ocular Therapeutix has submitted a premarket approval application to the U.S. Food and Drug Administration for ReSure sealant, according to a company news release.The sealant, which uses the company’s proprietary hydrogel technology, has the proposed indication of intraoperatively managing clear corneal incisions with a wound leak and preventing fluid egress after cataract surgery or IOL placement, the release said.

Carl Zeiss Meditec introduces data management options for Forum system

Carl Zeiss Meditec has announced the release of new management software and a glaucoma management application to expand the offerings of its Forum eye care data management system.The Forum Glaucoma Workplace will allow physicians to combine Cirrus optical coherence tomography and Humphrey Field Analyzer perimetry information and interactively review patients’ visual field data, according to a news release.

Eylea drives increase in net income for Regeneron

Regeneron Pharmaceuticals reported a net income of $750.3 million in 2012, compared with a net loss of $221.8 million in 2011, according to a company press release.Revenues increased from $445.8 million in 2011 to $1.4 billion in 2012. Eylea (aflibercept) accounted for $838 million in U.S. net sales in 2012, leading to Regeneron’s first full year of profitability, according to the release.

Intracorneal ring segments may not halt progressive keratoconus in long term

WARSAW, Poland — Implantation of intracorneal ring segments in young keratoconus patients may not be able to stop the progressive nature of the disease, even though it may provided a significant short-term improvement in visual, refractive and topographic status, according to one surgeon.”Several studies have shown the efficacy of this procedure in improving [visual acuity] and flattening the central cornea. However, there is no scientific data to support that corneal ring segment implantation can halt the progressive nature of the disease,” Alfredo Vega-Estrada, MD, said at the winter meeting of the European Society of Cataract and Refractive Surgeons.

Accelerated corneal cross-linking may prevent astigmatism after cataract surgery

WARSAW, Poland — Accelerated corneal cross-linking may be employed in cataract surgery to manipulate clear corneal incisions and prevent surgery-induced astigmatism, according to one surgeon.”Clear corneal incisions produce dramatic changes in topometric maps. These astigmatic changes may go away with time but may otherwise be a factor of poor visual function, especially with multifocal or toric lenses,” John Kanellopoulos, MD, said at an industry-sponsored symposium held during the winter meeting of the European Society of Cataract and Refractive Surgeons.

New aspheric aberration profile shows safety, efficacy in treatment of hyperopic astigmatism

WARSAW, Poland — Aspheric femtosecond LASIK offers a reliable method for correction of hyperopic astigmatism, according to one surgeon.The prevalence of hyperopia tends to decline with age, but latent forms often become significant with the onset of presbyopia. Laser treatment is a well-established procedure but not as straightforward as it is for myopic correction, Thomas Kohnen, MD, said at the winter meeting of the European Society of Cataract and Refractive Surgeons.

Improvements in multifocal IOLs increasing opportunity for spectacle independence

WARSAW, Poland — Steady advances in multifocal IOL technology could make monofocality obsolete in the near future, according to a speaker.”Recent improvements and new designs have solved or minimized the problems of multifocal IOLs, and new options like the toric component, the low near power and the trifocal technology have increased the opportunities for spectacle independence,” Roberto Bellucci, MD, said at the winter meeting of the European Society of Cataract and Refractive Surgeons.

Intracorneal silicone injection may offer pain relief in eyes with bullous keratopathy

WARSAW, Poland — Intracorneal injection of a transparent, biocompatible hydrophobic material is a fast, minimally invasive and promising new technique for the treatment of bullous keratopathy, according to a specialist.The ideas was first developed by George D. Kymionis, MD, PhD, who observed during vitreoretinal surgery that silicone oil that penetrates into the anterior chamber works as a hydrophobic barrier, Ioannis G. Pallikaris, MD, PhD, said at the winter meeting of the European Society of Cataract and Refractive Surgeons.

Optimized beam profile increases efficacy of corneal cross-linking

WARSAW, Poland — The safety profile of corneal cross-linking has been confirmed through more than 15 years of follow-up, and continuous innovation has increased efficacy, according to a speaker.Summarizing cross-linking results to date and current complication rates at the winter meeting of the European Society of Cataract and Refractive Surgeons, Theo Seiler, MD, PhD, said that 1% of eyes experience two lines of vision loss. Recognized risk factors are age older than 35 years and preoperative best corrected visual acuity greater than 20/25.